Daelynn R. Buelow

Daelynn R. Buelow's research focuses on acute myeloid leukemia (AML), particularly how genetic mutations like FLT3 affect disease behavior and drug response, and how drugs are absorbed, processed, and cause side effects in the body (a field called pharmacology). Their work spans laboratory models (such as zebrafish and mice), clinical trial data, and studies on drug toxicity, including chemotherapy-related nerve damage and low white blood cell counts. This research aims to improve treatment strategies and understand drug resistance and side effects in leukemia and related cancers.

Publication output has grown substantially in recent years, surging from a handful of papers annually before 2022 to a large spike in 2023 and 2025, indicating an increasingly active and productive research program.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026